News
Right now, as investors get back into risk-taking mode, the market is suddenly re-discovering a lot of downtrodden tech stocks that were trading at...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I am a value focused investor. Stocks rise and fall for many different reasons that we often cannot...
News
This article was written by Follow I’m an Equity Analyst and Accountant specializing in restaurant stocks, with a strong foundation in Business Administration and...
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
BUD Has Fallen To The Cancel Culture We have previously covered Anheuser-Busch InBev SA/NV (BUD) in April 2023, suggesting that the controversy after the...
News
Introduction As a dividend growth investor, I seek investment opportunities in income-producing assets, mainly stocks. I usually add to existing positions when I find...
News
Amid the resurgence of optimism in the markets, we have to be careful of one thing: with investors piling back into tech stocks, we...
News
Introduction Founded in 2008, BioNTech (NASDAQ:BNTX) is an international leader in immunotherapy, aimed at innovating treatments for cancer, infectious diseases, and other severe illnesses....
News
One of my favorite financial planning clients represents a story that is part success, part sadness. Betty, we’ll call her, married young and became...
News
The oil and gas M&A boom is in full swing, with Earthstone Energy (NYSE:ESTE) recently having announced it was acquiring Novo Oil & Gas...
News
Annuities are setting sales records, thanks to higher interest rates, lower stock prices, and aging Baby Boomers. It’s been years since annuities were able...
News
Investment thesis Our current investment thesis is: IDEXX growth and margins are highly attractive, with no real financial downsides. Commercially, IDEXX has transitioned toward...
News
Investment Thesis CME Group (NASDAQ:CME) is currently down over 25% from its all-time high last year, as the financial companies continue to face pressure...
